ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

Cadmium cyanide

HCID 68335
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
542-83-6
標準SMILES
[C-]#N.[C-]#N.[Cd+2]
InChIKey
NHMJUOSYSOOPDM-UHFFFAOYSA-N
分子式
C2CdN2
平均分子量
164.45 g/mol
単同位体質量
165.909513

概要

Cadmium cyanide is a chemical compound of cadmium and cyanide prepared by treating a concentrated aqueous solution of cadmium chloride or cadmium nitrate with potassium cyanide or sodium cyanide. It is used as an electrolyte for electrodeposition of thin metallic cadmium coatings on metal to protect against corrosion. Cadmium is a transition metal and chemical element with the symbol Cd and atomic number 48. It is found naturally in the earth's crust, though rarely on it's own. (L6, L460)

名称と識別子

優先名称
Cadmium cyanide
IUPAC
cadmium(2+) dicyanide

名称と別名

Cadmium dicyanideL520HA8ZUKCADMIUM CYANIDE [MI]cadmiumdicarbonitrileRefChem:573228208-829-1542-83-6Cadmium cyanideCadmium cyanide (Cd(CN)2)EINECS 208-829-1SCHEMBL1147413NHMJUOSYSOOPDM-UHFFFAOYSA-N
名称をさらに表示
DB-052529NS00080275Q410497

データベース識別子

CAS
542-83-6
PubChem CID
68335
UNII
L520HA8ZUK
EC Number
208-829-1

物性

構造計算による物性

極性表面積
47.6 Ų
水素結合供与体数
0
水素結合受容体数
4
回転可能結合数
0
重原子数
5
形式電荷
0
複雑度
10

実験および物理化学的性質

Chemical ClassesMetals -> Cadmium Compounds, Inorganic
Physical DescriptionWhite solid; Slightly soluble in water (1.71 g/100mL at 15 deg C); [Merck Index]

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

Danger

H300: Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P262, P264, P270, P271, P273, P280, P284, P301+P316, P302+P352, P304+P340, P316, P318, P319, P320, P321, P330, P361+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Danger

H300: Fatal if swallowed [Danger Acute toxicity, oral]

P203, P260, P264, P270, P280, P301+P316, P318, P319, P321, P330, P405, and P501 (click each P-code to see the statement)

危険有害性情報

Regulatory Information · 2 件

Chemical: Cadmium cyanide (Cd(CN)2)

Restricted substance: Cadmium cyanide

Other Safety InformationIMAP assessments - Cadmium cyanide (Cd(CN)2): Human health tier II assessment
Hazards SummaryStable when stored in the absence of air and moisture; [Ullmann] Very toxic; [MSDSonline] See CYANIDES. See Cadmium and the linked diseases.
Hazard Classes and Categories · 3 件

Acute toxicity - category 1

Acute toxicity (Oral) - Category 2

Carc. 2

安全と保護具

Exposure Control and Personal Protection · 2 件

Biological Exposure Indices (BEI) [ACGIH] - Cd in urine = 5 ug/g creatinine; Cd in blood = 5 ug/L; sampling time not critical; Monitoring in blood should be preferred during the initial year of exposure and whenever changes in the degree of exposure are suspected. [ACGIH]

2.0 [mg/m3], inhalable fraction, as CN[German Research Foundation (DFG)]

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Cadmium and cyanide are absorbed from oral, inhalation, and dermal routes. Cadmium initially binds to metallothionein and albumin and is transported mainly to the kidney and liver. Toxic effects are observed once the concentration of cadmium exceeds that of available metallothionein, and it has also been shown that the cadmium-metallothionein complex may be damaging. Cadmium is not known to undergo any direct metabolic conversion and is excreted unchanged, mainly in the urine. Organic nitriles are converted into cyanide ions through the action of cytochrome P450 enzymes in the liver. Cyanide is rapidly absorbed and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L6, L96)

用途と製造

Uses · 3 件

Used in copper bright electroplating; [Merck Index]

Electroplating [Category: Plate]

Cadmium cyanide is used as an electrolyte for electrodeposition of thin metallic cadmium coatings on metal to protect against corrosion. (L460)

General Manufacturing InformationCadmium cyanide (Cd(CN)2): ACTIVE

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
Minimum Risk Level
Acute Inhalation: 0.00003 mg/m3 (Cadmium) (L134) Chronic Inhalation: 0.00001 mg/m3 (Cadmium) (L134) Intermediate Oral: 0.0005 mg/kg/day (Cadmium) (L134) Chronic Oral: 0.0001 mg/kg/day (Cadmium) (L134)
Threshold Limit Values (TLV)0.01 [mg/m3], as Cd ( 0.002 mg/m3, as Cd, respirable fraction)
Permissible Exposure Limit (PEL)0.005 [mg/m3], as Cd, see 29 CFR 1910.1027, (5 mg/m3, as CN)
Immediately Dangerous to Life or Health (IDLH)9.0 [mg/m3], as Cd (25 mg/m3, as CN)

毒性情報

Treatment · 1 件

Cadmium poisoning is treated by removal from exposure and supportive care. If ingested, induced vomiting or gastric lavage may be performed. Antidotes to cyanide poisoning include hydroxocobalamin and sodium nitrite, which release the cyanide from the cytochrome system, and rhodanase, which is an enzyme occurring naturally in mammals that combines serum cyanide with thiosulfate, producing comparatively harmless thiocyanate. Oxygen therapy can also be administered. (L97, L139)

Health Effects · 1 件

Chronic exposure to cadmium fumes can cause chemical pneumonitis, pulmonary edema, and lung diseases such as bronchitis and emphysema. Cadmium also accumulates in the kidneys, causing permanent damage. Loss of bone density also occurs. Exposure to high levels of cyanide for a short time harms the brain and heart and can even cause coma, seizures, apnea, cardiac arrest and death. Chronic inhalation of cyanide causes breathing difficulties, chest pain, vomiting, blood changes, headaches, and enlargement of the thyroid gland. Skin contact with cyanide salts can irritate and produce sores. (L6, L96, L97)

Adverse EffectsOther Poison - Chemical Asphyxiant
Exposure RoutesOral (L6) ; inhalation (L6) ; dermal (L6)
Toxicity Summary · 1 件

Cadmium initially binds to metallothionein and is transported to the kidney. Toxic effects are observed once the concentration of cadmium exceeds that of available metallothionein, and it has also been shown that the cadmium-metallothionein complex may be damaging. Accumulation of cadmium in the kidney results in increased excretion of vital low and high weight molecular proteins. Cadmium is a high affinity zinc analog and can interfere in its biological processes. It also binds to and activates the estrogen receptor, likely stimulating the growth of certain types of cancer cells and causing other estrogenic effects, such as reproductive dysfunction. Cadmium causes cell apoptosis by activating mitogen-activated protein kinases. Organic nitriles decompose into cyanide ions both in vivo and in vitro. Consequently the primary mechanism of toxicity for organic nitriles is their production of toxic cyanide ions or hydrogen cyanide. Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). It complexes with the ferric iron atom in this enzyme. The binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. As a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. Tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. Cyanide is also known produce some of its toxic effects by binding to catalase, glutathione peroxidase, methemoglobin, hydroxocobalamin, phosphatase, tyrosinase, ascorbic acid oxidase, xanthine oxidase, succinic dehydrogenase, and Cu/Zn superoxide dismutase. Cyanide binds to the ferric ion of methemoglobin to form inactive cyanmethemoglobin. (L8, A18, A19, A28, L97)

Signs and Symptoms · 1 件

Acute inhalation of cadmium fumes results in metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Ingestion of cadmium causes vomiting and diarrhea. Cyanide poisoning is identified by rapid, deep breathing and shortness of breath, general weakness, giddiness, headaches, vertigo, confusion, convulsions/seizures and eventually loss of consciousness. (L6, L96, L97)

Carcinogen Classification1, carcinogenic to humans. (L135)